← Back to Search

single photon emission computed tomography for Coronary Heart Disease (SPECT MBF Trial)

N/A
Waitlist Available
Led By Terrence Ruddy, MD
Research Sponsored by Ottawa Heart Institute Research Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

SPECT MBF Trial Summary

This trial is testing if a SPECT scan can get the same readings as a PET scan for diagnosing heart problems.

Eligible Conditions
  • Coronary Heart Disease

SPECT MBF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation
Reproducibility

SPECT MBF Trial Design

1Treatment groups
Experimental Treatment
Group I: Single photon emission computed tomographyExperimental Treatment1 Intervention
Myocardial blood flow (MBF) measurement will be analyzed using attenuation and scatter corrected dynamic single photon emission computed tomography (SPECT) imaging data. The data will be compared to MBF obtained from positron emission tomography (PET) imaging.

Find a Location

Who is running the clinical trial?

Ottawa Heart Institute Research CorporationLead Sponsor
188 Previous Clinical Trials
92,346 Total Patients Enrolled
GE HealthcareIndustry Sponsor
291 Previous Clinical Trials
631,006 Total Patients Enrolled
Terrence Ruddy, MDPrincipal InvestigatorOttawa Heart Institute Research Corporation
7 Previous Clinical Trials
765 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)
Terrence Ruddy 2014. "Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02280941.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top